Dapagliflozin-Mepha 10 mg, Filmtabletten - 98 Swissmedic Key 69915004 Registration Holder Mepha Pharma AG Name Dapagliflozin-Mepha 10 mg, Filmtabletten Date of registration 09.04.2025 Introduction of Sequence 09.04.2025 ATC-Classification Dapagliflozin (A10BK01) Revision date WHO WHO-DDD Valid until 08.04.2030 Index Therapeuticus (BSV) Show package size 98 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680699150045 Medication Code Synthetika Pharmacode Disponibility
Composition dapagliflozinum 10 mg, cellulosum microcristallinum, lactosum 50 mg, crospovidonum, silica colloidalis anhydrica, natrii stearylis fumaras, Überzug: natrii laurilsulfas, poly(alcohol vinylicus), macrogolum 3350, E 171, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 0.525 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dapagliflozinum 10 mg
Inactive agents Dose additional_information (Flavum) Cellulosum Microcristallinum Crospovidonum E 171 color. E 172 color. Lactosum 50 mg Macrogol 3350 Natrii Laurilsulfas Überzug Natrii Stearylis Fumaras Poly(Alcohol Vinylicus) Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 07.05.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
